You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LXH254, CRAF, MAPK, solid tumor, PDR001

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

Terminated
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
Sep 20, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Advanced Cancer, Metastatic Cancer, Solid Tumor Trial in United States (JZP815)

Recruiting
  • Advanced Cancer
  • +2 more
  • Denver, Colorado
  • +4 more
Jan 10, 2023

Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

Completed
Has Results
  • Melanoma
  • +4 more
  • PDR001
  • Baltimore, Maryland
  • +40 more
Aug 2, 2022

Advanced Solid Tumors With MAPK Pathway Mutations Trial in Nedlands (D3S-002)

Not yet recruiting
  • Advanced Solid Tumors With MAPK Pathway Mutations
  • Nedlands, Western Australia, Australia
    D3 Bio Investigative Site
May 24, 2023

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
Has Results
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
Jun 7, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Resistance-associated Mutations in Metastatic Lung Cancer

Recruiting
  • Lung Cancer
  • Liquid biopsy
  • Monza, MB, Italy
    Fondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023

NSCLC, Melanoma Trial in Worldwide (LXH254, LTT462, Trametinib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Melanoma
  • San Diego, California
  • +31 more
Sep 12, 2022

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
Has Results
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

NSCLC Trial in Worldwide (PDR001, Cisplatin, Gemcitabine)

Terminated
  • Non-small Cell Lung Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 11, 2022

Solid Tumors Trial in Worldwide (KAZ954, PDR001, NIR178)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +12 more
Dec 23, 2022

Advanced Solid Tumors Harboring MAPK Pathway Alterations Trial in Shandong (QLH11906)

Recruiting
  • Advanced Solid Tumors Harboring MAPK Pathway Alterations
  • Shandong, China
    Shandong Cancer Hospital
Aug 3, 2022